FDA Works To Ease “Traumatic” Advisory Committee Process – Ganley
This article was originally published in The Tan Sheet
Executive Summary
Recognizing that planning and conducting advisory committee meetings can be "traumatic" for both government and industry, FDA is taking steps to improve the process, said Charles Ganley, the head of the agency's OTC drugs program
You may also be interested in...
OTC Basics Included In Training To Improve FDA Advisory Committee Process
FDA will include basic over-the-counter drug processes in training this week for all advisory committee members
OTC Basics Included In Training To Improve FDA Advisory Committee Process
FDA will include basic over-the-counter drug processes in training this week for all advisory committee members
OTC Basics Included In Training To Improve FDA Advisory Committee Process
FDA will include basic over-the-counter drug processes in training this week for all advisory committee members